精密診斷市場規模、佔有率和成長分析（按產品類型、應用、最終用戶和地區）- 產業預測 2025-2032

全球精準診斷市場規模預估2023年為680.7億美元，2024年為805.9億美元，2032年為3,112.6億美元，2025-2032年的複合年成長率為18.4%。

精準診斷透過針對患者的健康問題（尤其是在糖尿病和癌症治療方面）提供及時且個人化的見解，徹底改變了醫療保健領域。由於癌症和神經系統疾病發病率的上升，精準醫療的需求正在飆升。美國國家癌症美國預測，到 2031 年，全球將新增 2,950 萬癌症病例，新增 1,640 萬癌症相關死亡病例。癌症、結核病和阿茲海默症症等疾病的基因治療和精準醫療的進步預計將推動收益大幅成長。精準診斷和治療方法的可自訂性是一個關鍵優勢，可以實現個人化的治療方法而不是通用的解決方案，從而改善患者的治療效果和醫療效率。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 技術進步
• 監管格局
• 專利分析

精準診斷市場規模（依產品類型）

• 市場概況
• 耗材
  • 試劑
  • 套件
  • 測定
• 裝置
  • 次世代定序(NGS) 系統
  • 聚合酵素鏈鎖反應（PCR）系統
  • 質譜儀系統
  • 其他
• 軟體和服務
  • 資料分析軟體
  • 生物資訊服務
  • 諮詢服務

精準診斷市場規模（按類型）

• 市場概況
• 基因檢測
• 消費者測試
• 深奧的測試
• 其他

精準診斷市場規模（按應用）

• 市場概況
• 腫瘤學
  • 乳癌
  • 肺癌
  • 大腸直腸癌
  • 其他
• 心臟病學
• 神經病學
• 感染疾病
• 其他

精準診斷市場規模（依最終用戶分類）

• 市場概況
• 醫院
• 診斷實驗室
• 研究組織
• 其他

精準診斷市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• Roche（Switzerland）
• GE Healthcare（United States）
• Abbott Laboratories（United States）
• Philips Healthcare（Netherlands）
• Danaher Corporation（United States）
• Quest Diagnostics（United States）
• Fujifilm Medical（Japan）
• Becton, Dickinson and Company（United States）
• Siemens Healthineers（Germany）
• Hologic Inc.（United States）
• QIAGEN（Germany）
• Grifols（Spain）
• Beckman Coulter（United States）
• bioMerieux（France）
• Thermo Fisher Scientific（United States）
• PerkinElmer（United States）
• Illumina（United States）
• Agilent Technologies（United States）
• Bio-Rad Laboratories（United States）
• Merck Group（Germany）

結論和建議

Global Precision Diagnostics Market size was valued at USD 68.07 billion in 2023 and is poised to grow from USD 80.59 billion in 2024 to USD 311.26 billion by 2032, growing at a CAGR of 18.4% during the forecast period (2025-2032).

Precision diagnostics is revolutionizing healthcare by providing tailored, timely insights into patients' health issues, particularly in diabetes and cancer treatment. Given the escalating incidence of cancer and neurological disorders, demand for precision medicine is set to soar. The National Cancer Institute projects a staggering increase of 29.5 million new cancer cases by 2031, alongside a 16.4 million rise in cancer-related fatalities. Advances in gene therapy and precision treatments for conditions like cancer, tuberculosis, and Alzheimer's are expected to drive significant revenue growth. The customizable nature of precision diagnostics and therapies is a critical advantage, allowing for personalized treatment approaches rather than a generic solution, thereby enhancing patient outcomes and healthcare efficiency.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Precision Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Precision Diagnostics Market Segmental Analysis

Global Precision Diagnostics Market is segmented by Product Type, Type, Application, End-User and region. Based on Product Type, the market is segmented into Consumables, Instruments and Software & Services. Based on Type, the market is segmented into Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Others. Based on Application, the market is segmented into Oncology, Cardiology, Neurology, Infectious Diseases and Others. Based on End-User, the market is segmented into Hospitals, Diagnostic Laboratories, Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Precision Diagnostics Market

The Global Precision Diagnostics market is being driven significantly by the rising demand for personalized therapy, which has gained traction in recent years. Essential tools such as genetic testing and genome sequencing are pivotal in unraveling the molecular foundations of various diseases. In many European nations, there is a proactive approach to screening for genetic disorders, as early detection can mitigate symptoms and lessen disease severity. Additionally, the COVID-19 pandemic highlighted the importance of diagnostic testing in managing outbreaks. Pharmaceutical and biotech firms are actively pursuing preclinical and clinical trials for innovative therapies, including plasma and immunotherapy. This momentum is expected to fuel market growth throughout the forecast period.

Restraints in the Global Precision Diagnostics Market

The Global Precision Diagnostics market faces several restraints that could impede its growth potential, primarily due to a lack of awareness and substantial costs associated with research and development. High R&D expenses deter innovation and advancement in precision diagnostics. While accurate diagnosis remains a top priority for healthcare providers, challenges such as the demand for quicker test results, inefficiencies in current testing methods, and regulatory hurdles for new test kit development further complicate market progress. Additionally, the strict regulatory landscape in many nations continues to pose significant barriers, ultimately hampering the overall expansion of the precision diagnostics sector.

Market Trends of the Global Precision Diagnostics Market

The Global Precision Diagnostics market is experiencing a significant upward trend, driven primarily by the alarming increase in cancer prevalence worldwide. As cancer cases rise, there is an intensified focus on enhancing detection, prevention, and treatment protocols. Innovations such as Next Generation Sequencing (NGS) and the integration of extensive genomic data are revolutionizing the diagnostic landscape, leading to more tailored and effective therapeutic strategies. This fusion of technological advancements and a growing demand for precision medicine is poised to fuel robust growth in the market throughout the forecast period, positioning it as a critical component of modern healthcare solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Advancement
• Regulatory Landscape
• Patent Analysis

Global Precision Diagnostics Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Consumables
  • Reagents
  • Kits
  • Assays
• Instruments
  • Next-Generation Sequencing (NGS) Systems
  • Polymerase Chain Reaction (PCR) Systems
  • Mass Spectrometry Systems
  • Others
• Software & Services
  • Data Analysis Software
  • Bioinformatics Services
  • Consulting Services

Global Precision Diagnostics Market Size by Type & CAGR (2025-2032)

• Market Overview
• Genetic Tests
• Direct to Consumer Tests
• Esoteric Tests
• Others

Global Precision Diagnostics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Oncology
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Others
• Cardiology
• Neurology
• Infectious Diseases
• Others

Global Precision Diagnostics Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Others

Global Precision Diagnostics Market Size & CAGR (2025-2032)

• North America (Product Type, Type, Application, End-User)
  • US
  • Canada
• Europe (Product Type, Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Type, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Medical (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations